Authored By: Tyreze Chivaz Naidoo
Emeris
- Case Citation and Basic Information
Minister of Health and Others v. Treatment Action Campaign and Others (No 2), 2002 (5) SA 721 (CC), Constitutional Court of South Africa (11-Judge Bench), decided 5 July 2002.
Full Case Name: Minister of Health and Others v. Treatment Action Campaign and Others (No 2)
Citation: 2002 (5) SA 721 (CC); Case No. CCT 8/2002
Court: Constitutional Court of South Africa
Date of Decision: 5 July 2002 (Heard: May 2, 3, and 6, 2002)
Bench Composition: Chaskalson CJ, Langa DCJ, Ackermann J, Goldstone J, Kriegler J, Madala J, Ngcobo J, O’Regan J, Sachs J, Du Plessis AJ, and Skweyiya AJ (Unanimous 11-Judge Constitutional Bench)
Counsel for Appellants: M T K Moerane SC, P Coppin, and B Vally for the Appellants (Minister of Health and Provincial Health MECs)
Counsel for Respondents: G J Marcus SC, B C Majola, and G M Budlender (Attorney) for the Respondents (Treatment Action Campaign et al.)
Amici Curiae: W H Trengove SC, N Bawa, A C Dodson, and K Pillay for 1st & 2nd Amici Curiae; S J Cowen for 3rd Amicus Curiae
- Introduction
The decision of the Constitutional Court of South Africa in Minister of Health and Others v. Treatment Action Campaign and Others (No 2) is widely acknowledged as one of the most significant socio-economic rights judgments in post-apartheid constitutional jurisprudence. Delivered amidst a catastrophic HIV/AIDS pandemic that infected tens of thousands of infants annually through mother-to-child transmission, the case confronted the governmental policy that restricted access to Nevirapine, a registered, life-saving antiretroviral drug, strictly to a small number of pilot research sites. The central constitutional inquiry concerned whether the government’s refusal to permit public health doctors outside designated research sites to prescribe Nevirapine violated the constitutional rights of access to health care services under Section 27 and the fundamental rights of children under Section 28 of the South African Constitution. Furthermore, the ruling addressed pivotal questions regarding the separation of powers and the constitutional authority of the judiciary to issue mandatory and supervisory remedies against the Executive to enforce socio-economic entitlements.
- Facts of the Case
At the onset of the twenty-first century, South Africa faced an unprecedented public health crisis caused by the HIV/AIDS pandemic. Government estimates revealed that approximately 70,000 children were contracting HIV every year, predominantly through vertical mother-to-child transmission (MTCT) during childbirth. In 1998, the South African Medicines Control Council (MCC) officially registered Nevirapine, an antiretroviral drug, affirming its safety, quality, and therapeutic efficacy. Subsequently, in January 2001, the World Health Organization (WHO) formally recommended the administration of a single dose of Nevirapine to an HIV-positive mother during labour and a single dose to her newborn child within 72 hours of birth as an effective, simple, and safe intervention to drastically reduce intrapartum transmission. In July 2000, the manufacturer of Nevirapine offered to supply the drug free of charge to the South African government for five years for mother-to-child transmission prevention.
Despite the registration of Nevirapine, its international approval, and the manufacturer’s free offer, the national Department of Health announced in August 2000 that Nevirapine would not be made generally available within the public health sector. Instead, the government formulated a policy that confined the distribution and administration of Nevirapine exclusively to two designated pilot research and training sites per province (covering approximately 10% of births in the public sector). Public sector doctors working outside these designated pilot sites were strictly prohibited from prescribing Nevirapine to HIV-positive pregnant women, even where testing and counselling facilities already existed and where the drug was medically indicated.
The government justified this restrictive restriction on several grounds: the need to evaluate the operational challenges of delivering a ‘full package’ of care (including voluntary counselling, testing, formula feeding, and long-term monitoring); concerns over potential viral resistance; hypothetical long-term safety risks; and institutional capacity and budgetary constraints. In August 2001, the Treatment Action Campaign (TAC), alongside other civil society organizations, launched constitutional proceedings in the High Court of South Africa (Transvaal Provincial Division) challenging the government’s policy. On 14 December 2001, Botha J ruled in favour of TAC, declaring the policy unconstitutional and ordering the government to make Nevirapine available nationwide. The Minister of Health and provincial Health MECs appealed the decision directly to the Constitutional Court.
- Legal Issues
The Constitutional Court identified and evaluated three primary legal questions:
Issue 1: Whether the government’s policy of restricting the supply of Nevirapine exclusively to designated research and training pilot sites, while prohibiting its prescription at other public health facilities where testing and counselling existed, constituted an unreasonable measure that breached the State’s constitutional obligations to provide access to health care services under Section 27(1)(a) and Section 27(2) of the Constitution?
Issue 2: Whether the government was constitutionally obliged under Sections 27 and 28(1)(c) of the Constitution to devise, publish, and implement a comprehensive, coordinated national plan with clear timeframes to prevent mother-to-child transmission of HIV throughout South Africa?
Issue 3: Whether the doctrine of separation of powers restricts the judiciary strictly to issuing declaratory relief when executive socio-economic policy is found unconstitutional, or whether courts possess the constitutional mandate under Sections 38 and 172(1) to issue mandatory and supervisory orders compelling executive action?
- Arguments Presented
5.1 Petitioner / Appellant’s Arguments (The Applicants / Respondents in Appeal – TAC)
Violation of Constitutional Rights: The government’s blanket prohibition on prescribing Nevirapine outside pilot sites infringed Section 27(1)(a) (right of access to health care services) and Section 28(1)(c) (children’s right to basic health care services). Indigent pregnant women and newborn infants outside pilot sites were arbitrarily denied a life-saving intervention available in the private sector.
Irrationality and Unreasonableness: Nevirapine was registered by the MCC, recommended by WHO, and offered free of charge. Where health facilities possessed counselling and testing infrastructure, withholding a simple, single-dose regimen was medically, logically, and legally indefensible. Concerns regarding formula feeding or drug safety did not justify denying immediate life-saving treatment.
Lack of a Comprehensive National Programme: The State failed to discharge its positive obligation under Section 27(2) to plan and roll out a progressive, nationwide MTCT prevention strategy with clear implementation timeframes, leaving thousands of infants to contract avoidable infections.
5.2 Respondent’s Arguments (The Appellants in Appeal – Minister of Health & Health MECs)
The Minister of Health and provincial health authorities advanced the following arguments in defence:
Need for a Comprehensive Operational Package: The government argued that Nevirapine could not be administered in isolation. Effective MTCT prevention required a complex ‘full package’ encompassing voluntary counselling, rapid testing, substitute infant formula feeding, and continuous clinical monitoring. Confining drug delivery to pilot sites was necessary to gather operational research and evaluate sustainability.
Resource Constraints and Progressive Realization: Relying on Section 27(2), the State argued that socio-economic rights are limited by available resources and achievable only progressively. Health systems were overextended, staff were undertrained, and public funds were constrained.
Separation of Powers and Judicial Restraint: Counsel for the State submitted that formulating health policy and allocating public budgets lie exclusively within executive prerogative. They contended that courts lack institutional competence to evaluate healthcare policy and that, even if unconstitutionality were found, judicial relief must be strictly confined to declaratory orders rather than mandatory interdicts.
- Court’s Reasoning and Analysis
In a unanimous judgment delivered by the Court, the Constitutional Court systematically evaluated the constitutional framework governing socio-economic rights, the unreasonableness of the government’s policy, and the appropriate scope of judicial remedies.
6.1 Socio-Economic Rights Framework and ‘Minimum Core’
The Court reaffirmed its constitutional jurisprudence established in Soobramoney v. Minister of Health (1998) and Government of the Republic of South Africa v. Grootboom (2001). Addressing arguments raised by amici curiae regarding a self-standing ‘minimum core’ entitlement, the Court clarified that Sections 27(1) and 27(2) must be read together as a unified whole. Section 27(1) does not confer an individual, immediate right enforceable on demand regardless of resource constraints. Rather, the State’s primary obligation under Section 27(2) is to take reasonable legislative and other measures, within available resources, to achieve the progressive realization of access to health care. However, the Court emphasized that ‘minimum core’ concepts remain relevant in evaluating whether state measures are legally ‘reasonable.’
6.2 Unreasonableness of the Restrictive Nevirapine Policy
Applying the standard of reasonableness, the Court held that a government program aimed at realizing socio-economic rights must be balanced, flexible, and inclusive. Crucially, a policy that excludes a significant segment of society, especially those whose needs are most urgent and whose rights are most in peril, fails the test of constitutional reasonableness. The Court observed that the financial cost of Nevirapine was non-existent because of the manufacturer’s five-year free offer. The administration of Nevirapine involved a simple, single-tablet procedure for the mother and a few drops for the baby. Where testing and counselling infrastructure already existed outside pilot sites, withholding the drug was completely unjustifiable.
The Court dissected each reason advanced by the State: efficacy concerns were undermined by scientific consensus showing that single-dose Nevirapine saves lives even when mothers breastfeed; resistance risks were transient and outweighed by the lethal alternative of infection; and safety was fully established by MCC registration and WHO endorsement. The Court concluded that waiting for two-year pilot studies while thousands of infants died represented an inflexible, unreasonable approach that infringed Section 27(2) read with Section 27(1)(a).
6.3 Children’s Rights under Section 28
The Court examined Section 28(1)(c), which guarantees every child the right to basic health care services. While primary responsibility for childcare rests on parents who can afford it, the State incurs an immediate constitutional obligation toward children born to indigent mothers in public health facilities who cannot afford private care. In such context, denying life-saving medical interventions profoundly impaired children’s foundational rights to life and basic health care.
6.4 Separation of Powers and Remedial Authority
The Court emphatically rejected the government’s argument that the separation of powers restricts judicial remedies strictly to declaratory orders. Under Section 38 (granting ‘appropriate relief’) and Section 172(1)(a) (mandating declarations of invalidity alongside ‘just and equitable’ orders), South African courts possess wide remedial powers. Where executive policy breaches the Constitution, the Judiciary is constitutionally required to intervene and issue mandatory relief (including mandamus and supervisory interdicts) to ensure effective vindication of constitutional rights.
- Judgment and Ratio Decidendi
7.1 The Order of the Court
The Constitutional Court set aside the order of the High Court and substituted a unified, binding order:
- Declaration of Unconstitutionality: Declared that Sections 27(1) and (2) require the government to devise and implement a comprehensive, coordinated national programme to realize progressively the rights of pregnant women and newborn infants to health services to combat MTCT of HIV. The government’s existing policy fell short of constitutional standards by restricting Nevirapine to research sites and failing to train public health counsellors elsewhere.
- Mandatory Injunctions: Ordered government without delay to: (a) remove restrictions preventing Nevirapine from being made available at public hospitals and clinics outside pilot sites; (b) permit and facilitate its prescription whenever medically indicated; (c) train public health counsellors in Nevirapine administration; and (d) take reasonable measures to extend testing and counselling facilities across the public health sector.
- Flexibility and Costs: Clarified that government retains the right to adapt its policy if equally effective or superior MTCT prevention methods emerge. Ordered the State to pay the applicants’ legal costs.
7.2 Ratio Decidendi
The binding legal principles established by the decision are twofold:
- Reasonableness in Socio-Economic Rights: A government policy concerning socio-economic rights under Section 27 of the Constitution must be reasonable, flexible, and non-exclusionary. Restricting access to a registered, proven, safe, and free life-saving medicine (Nevirapine) where health care infrastructure and capacity exist is constitutionally unreasonable and invalid.
- Judicial Remedial Power over Executive Policy: Under Sections 38 and 172 of the Constitution, courts possess broad authority to grant mandatory and supervisory relief against the Executive to compel compliance with socio-economic rights obligations without violating the doctrine of separation of powers.
- Critical Analysis
8.1 Significance of the Decision
The Treatment Action Campaign (No 2) decision represents a landmark watershed in global constitutionalism and human rights jurisprudence. It established that socio-economic rights enshrined in national constitutions are not mere aspirational directives but fully enforceable rights capable of judicial vindication. By holding the Executive accountable during a major public health emergency, the judgment affirmed the supremacy of the Constitution and demonstrated the vital role of judicial review in safeguarding vulnerable populations.
8.2 Implications and Impact
The practical implications of the ruling were profound and far-reaching. Legally, it compelled the immediate national rollout of Nevirapine across South African public hospitals and clinics, directly preventing hundreds of thousands of infants from contracting HIV and saving innumerable lives. Institutionally, the decision catalysed the creation of South Africa’s comprehensive national antiretroviral treatment program, which grew into the largest public HIV treatment framework in the world. Politically, the case exemplified the transformative power of strategic civil society litigation, establishing the Treatment Action Campaign as a formidable model for public interest advocacy.
8.3 Critical Evaluation
From a doctrinal perspective, the Court’s reasoning is commendable for its principled pragmatic balance. By rejecting the rigid ‘minimum core’ doctrine in favour of a contextual ‘reasonableness’ standard, the Court respected executive administrative flexibility while maintaining robust constitutional oversight. The Court rightly identified that where a life-saving intervention is available at zero material cost, executive refusal to distribute it constitutes clear constitutional unreasonableness.
However, scholarly evaluation highlights minor limitations. Some constitutional commentators argue that by declining to issue a structural supervisory interdict requiring regular court reporting, the Court placed undue reliance on executive compliance. While government ultimately complied, subsequent administrative delays in healthcare delivery underscored the potential utility of ongoing judicial supervision in complex socio-economic implementation. Nevertheless, the decision achieved an optimal constitutional balance between judicial firmness and institutional deference.
- Conclusion
In conclusion, Minister of Health v. Treatment Action Campaign (No 2) stands as a monumental legal precedent in South African constitutional democracy. The Constitutional Court successfully reconciled socio-economic rights enforcement with the separation of powers, establishing that state policies must prioritize vulnerable segments of society whose fundamental rights are most severely threatened.
The single most essential takeaway from this decision is that executive discretion in socio-economic policy is bounded by the constitutional mandate of reasonableness. When the State possesses the capacity and resources to provide a life-saving medical treatment, excluding affected citizens from access is legally indefensible. The lasting legacy of TAC (No 2) lies not only in the hundreds of thousands of infant lives saved, but in establishing an enduring legal blueprint for enforcing human dignity, state accountability, and healthcare justice.
- References
- Minister of Health and Others v. Treatment Action Campaign and Others (No 2) 2002 (5) SA 721 (CC).
- Government of the Republic of South Africa and Others v. Grootboom and Others 2001 (1) SA 46 (CC).
- Soobramoney v. Minister of Health, KwaZulu-Natal 1998 (1) SA 765 (CC).
- Ferreira v. Levin NO and Others; Vryenhoek and Others v. Powell NO and Others 1996 (1) SA 984 (CC).
- August and Another v. Electoral Commission and Others 1999 (3) SA 1 (CC).
- Constitution of the Republic of South Africa Act 108 of 1996, Sections 7, 8, 27, 28, 38, 172.
- World Health Organization, Technical Consultation: New Data on the Prevention of Mother-to-Child Transmission of HIV and Their Policy Implications (Geneva, 2001).
- United Nations Committee on Economic, Social and Cultural Rights, General Comment No. 3: The Nature of States Parties’ Obligations (Art. 2, Para. 1 of the Covenant) (1990).

